.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2013 for an immense ...
.On the heels of a phase 3 gain that fell short to impress capitalists, Ironwood Pharmaceuticals is ...
.Do not quit Monte Rosa Rehabs right now. The Boston-based biotech is actually having a ball after a...
.Welcome to today's Chutes & Ladders, our roundup of considerable management hirings, shootings a...
.Celebrating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer s...
.AbbVie has actually gone back to the resource of its own antipsychotic giant Vraylar searching for ...
.GenSight Biologics is full weeks far from lacking cash. Once more. The biotech simply has enough mo...
.Monopar Therapies is actually recuperating a medication coming from the scrap heap of AstraZeneca's...
.Along with new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of analysts ...
.After forming a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is actually back f...